The report, now available on ASDReports, recognizes the following companies as the key players in the Global Acute Lymphocytic Leukemia Market: Amgen, Bristol-Myers Squibb and Novartis
Other Prominent Vendors in the market are: Ariad, Arno Therapeutics, Baxter, Boehringer Ingelheim, ERYTECH Pharma, Fate Therapeutics, Jazz Pharmaceuticals, Orphan Europe, Otsuka, Ono Pharmaceuticals, Onconova Therapeutics, Pfizer, Regeneron Pharmaceuticals, Sanofi, and Sigma-Tau Pharmaceuticals.
Commenting on the report, an analyst said: “The rise in awareness programs to treat acute lymphocytic leukemia patients is one such trend. It increases the treatment-seeking rate among patients, which results in an increase in overall consumption of medicines.”
According to the report, the global acute lymphocytic leukemia therapeutics market is driven by several factors. The presence of high unmet needs for appropriate drugs is one of the major factors propelling the growth of the market. Current treatment options cannot cure the disease completely, hence the demand remains high. Therefore, drugs that can cause disease remission in patients are expected to drive the growth of the market.
Further, the report states that the high cost of treatment is one of the major challenges hindering the growth of the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.